TGFB1 and neoplasm: Tregs suppress anti-tumor immune responses by inhibiting the activity of effector T cells and natural killer (NK) cells through the secretion of immunosuppressive cytokines such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β) [26].